13F filings are disclosed up to 45 days after quarter-end. Holdings shown are as of each quarter-end (latest filing 2026-08-14) and may differ from current positions. 13F reports only US-listed long equities — shorts, most derivatives, non-US (e.g. Korea/Japan) names, and confidential treatment are excluded.
Viking Global
CIK 1103804Andreas Halvorsen · Viking Global Investors LP
Another Tiger cub — a fundamental long/short shop running healthcare and tech broadly.
View original 13F on SEC EDGARQuarter
2026Q2
Total 13F value
$35.1B
Holdings
90
Top holdings
| Holding | Weight | % of 13F | Value |
|---|---|---|---|
| Visa Inc | 6.25% | $2.2B | |
| Taiwan Semiconductor Manufac | 4.31% | $1.5B | |
| Air Products And Chemicals I | 3.96% | $1.4B | |
| Sherwin Williams Co | 3.80% | $1.3B | |
| Fortive Corp | 3.47% | $1.2B | |
| Meta Platforms Inc | 3.00% | $1.1B | |
| Schwab Charles Corp | 2.80% | $982M | |
| Thermo Fisher Scientific Inc | 2.77% | $971M | |
| Jpmorgan Chase & Co | 2.71% | $949M | |
| Lennox Intl Inc | 2.60% | $912M |
As of 2026Q2 · filed 2026-08-14 · accession 0001103804-26-000006 · 57 days after quarter-end · source SEC EDGAR Form 13F-HR
This page is a factual aggregation of public SEC EDGAR Form 13F-HR disclosures. It reflects only US-listed long equity holdings; shorts, derivatives, non-US, and confidential-treatment positions are excluded. 'Weight' means the position's share within that manager's 13F (a fact), not a portfolio allocation guide. This page is for information only and is not a recommendation to buy or sell any security, nor investment advice. All investment decisions are the sole responsibility of the investor. © 2026 Haerangdal Research.